Project Atlas
👁 71 Views
The BLA was never submitted. But was this project a failure? In regulatory consulting, success is often measured by a
Situation A US-based biopharmaceutical sponsor entered into a licensing agreement with a China-based ADC developer, securing exclusive rights to a
Situation An oncology-focused biopharmaceutical company with multiple gene therapy programs at various phases of clinical trials was preparing for a
ANDA Submissions for a US-based CRO
👁 51 Views
Situation The client was a US-based CRO acting as an US Agent for a Korea-based pharmaceutical company to submit three